| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 198481-32-2 | bazedoxifene | |
| |
| 173334-58-2 | 阿利克仑半富马酸盐
aliskiren hemifumarate | |
C30H53N3O6 | 551.76 |
| 533884-09-2 | ly500307 | |
C18H18O3 | 282.3 |
| 328543-09-5 | 2-(4-((二甲基氨基)甲基)苯基)-5,6-二氢咪唑并(4,5,1-jk)(1,4)苯并二氮杂卓-7(4h)-酮
ag14361 | |
C19H20N4O | 320.40 |
| 1174043-16-3 | 4-(4-氟-3-((4-甲氧基哌啶-1-基)羰基)苄基)酞嗪-1(2h)-酮
azd2461 | |
C22H22FN3O3 | 395.43 |
| 344458-19-1 | n-(6-氧代-5,6-二氢菲啶-2-基)-2-(n,n-二甲基氨基)乙酰胺
pj34 | |
C17H17N3O2 | 295.34 |
| 475479-34-6 | aleglitazar | |
C24H23NO5S | 437.51 |
| 467214-20-6 | 阿螺旋霉素
alvespimycin | |
C32H48N4O8 | 616.75 |
| 905579-51-3 | 氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1h-茚-1-基]氨基]-7h-吡咯并[2,3-d]嘧啶-7-基]-2-羟基环戊基]甲基酯
mln4924 | |
C21H25N5O4S | 443.52 |
| 1228960-69-7 | mln0905 | |
C24H25F3N6S | 486.56 |
| 955365-80-7 | mk-1775 | |
C27H32N8O2 | 500.61 |
| 869363-13-3 | 4-[[9-氯-7-(2,6-二氟苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2-基]氨基]苯甲酸
mln8054 | |
C25H15ClF2N4O2 | 476.86 |
| 1010085-13-8 | mk-5108 (vx-689) | |
C22H21ClFN3O3S | 461.94 |
| 902156-99-4 | at 9311；4-(2,6-二氯苯甲酰基氨基)-1h-吡唑-3-羧酸 n-[1-(甲基磺酰基)哌啶-4-基]酰胺
nvp-lcq195 | |
C17H19Cl2N5O4S | 460.33 |
| 398493-79-3 | n-(2,6-二乙基苯基)-4,6-二氢-3-((4-(4-甲基-1-哌嗪基)苯甲酰基)氨基)吡咯并(3,4-c)吡唑-5(1h)-甲酰胺
pha-680632 | |
C28H35N7O2 | 501.62 |
| 873436-91-0 | pu-h71 | |
C18H21IN6O2S | 512.37 |
| 898044-15-0 | pf-3758309 | |
C25H30N8OS | 490.62 |
| 718630-59-2 | 3-甲基-n-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-c]吡唑-3-基]丁酰胺
pha-793887 | |
C19H31N5O2 | 361.48 |
| 1085412-37-8 | pyridostatin | |
C31H32N8O5·xC2HF3O2 | 596.64 |
| 845714-00-3 | 1,5,6,7-四氢-2-(4-吡啶基)-4h-吡咯并[3,2-c]吡啶-4-酮
pha-767491 | |
C12H11N3O | 213.24 |
| 802539-81-7 | pha-848125 | |
C25H32N8O | 460.57 |
| 920113-03-7 | p276-00 | |
C21H20ClNO5·HCl | 438.3 |
| 1062243-51-9 | ro3280 | |
C27H35F2N7O3 | 543.61 |
| 1094069-99-4 | sch-1473759 | |
C20H26N8OS | 426.54 |
| 911417-87-3 | 2-[3-[4-[(1h-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-n-异丙基乙酰胺
2-[3-[4-[(1h-indazol-5-yl)amino]quinazolin-2-yl]phenoxy]-n-isopropylacetamide | |
C26H24N6O2 | 452.51 |
| 937270-47-8 | sb1317 | |
C23H24N4O | 372.46 |
| 1146618-41-8 | sns-314 mesylate | |
C18H15ClN6OS2·CH4O3S | 527.04 |
| 254964-60-8 | tasquinimod | |
C20H17F3N2O4 | 406.36 |
| 934541-31-8 | tak-901 | |
C28H32N4O3S | 504.64 |
| 639089-54-6 | 陶扎色替
tozasertib | |
C23H28N8OS | 464.60 |
| 175414-77-4 | voreloxin | |
C18H19N5O4S | 401.44 |
| 755038-65-4 | n-(反式-4-(4-(环丙基甲基)-1-哌嗪基)环己基)-4-(((7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基)氨基)-3-甲氧基苯甲酰胺
volasertib (bi 6727) | |
C34H50N8O3 | 618.83 |
| 90332-66-4 | 7-xylosyltaxol | |
C52H59NO18 | 986.02 |
| 199433-58-4 | y-33075 | |
C16H16N4O | 280.32 |
| 331771-20-1 | n-[4-[[6-甲氧基-7-[3-(4-吗啉基)丙氧基]-4-喹唑啉基]氨基]苯基]苯甲酰胺
zm-447439 | 密度：1.282 g/cm3
熔点：117-120°C
沸点：639.671°C
|
C29H31N5O4 | 513.6 |
| 582315-72-8 | bms-265246 | |
C18H17F2N3O2 | 345.34 |
| 199113-98-9 | 巴格列酮
balaglitazone | |
C20H17N3O4S | 395.44 |
| 935693-62-2 | 2-(六氢-4-甲基-1h-1,4-二氮杂卓-1-基)-6,7-二甲氧基-n-(1-(苯基甲基)-4-哌啶基)-4-喹唑啉胺
bix-01294 | 熔点：178.44° C
|
C28H38N6O2 | 490.64 |
| 1092443-52-1 | bs-181 | |
C22H32N6 | 380.53 |
| 755038-02-9 | 4-[[(7R)-8-环戊基-7-乙基-5,6,7,8-四氢-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-n-(1-甲基-4-哌啶基)苯甲酰胺
bi 2536 | |
C28H39N7O3 | 521.66 |
| 405168-58-3 | chir-124 | |
C23H22ClN5O | 419.91 |
| 164658-13-3 | cgp60474 | |
C18H18ClN5O | 355.82 |
| 1333377-65-3 | chr-6494 trifluoroacetate salt | |
C16H16N6 | 292.34 |
| 1262849-73-9 | cct241533 | |
C23H27FN4O4 | 442.48 |
| 693228-63-6 | cyc116 | |
C18H20N6OS | 368.46 |
| 942947-93-5 | cct129202 | |
C23H25ClN8OS | 497.02 |
| 779353-01-4 | (2S)-1-(3-乙基-7-(((1-氧代-3-吡啶基)甲基)氨基)吡唑并(1,5-a)嘧啶-5-基)-2-哌啶乙醇
sch 727965 | |
C21H28N6O2 | 396.49 |
| 290304-24-4 | daun02 | |
C41H44N2O20 | 884.79 |
| 827318-97-8 | 达鲁舍替
danusertib (pha-739358) | 密度：1.322g/ml
沸点：664.149℃ at 760 mmHg
|
C26H30N6O3 | 474.55 |
| 74588-78-6 | d-64131 | |
C16H13NO2 | 251.28 |
